nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—HTR2A—pulmonary artery—sarcoma	0.00492	0.118	CbGeAlD
Duloxetine—NPY1R—myometrium—sarcoma	0.00431	0.104	CbGeAlD
Duloxetine—NPY1R—seminal vesicle—sarcoma	0.0039	0.0939	CbGeAlD
Duloxetine—NPY1R—hematopoietic system—sarcoma	0.0037	0.0892	CbGeAlD
Duloxetine—HTR2A—hindlimb—sarcoma	0.00297	0.0716	CbGeAlD
Duloxetine—HTR2A—appendage—sarcoma	0.00255	0.0614	CbGeAlD
Duloxetine—NPY1R—testis—sarcoma	0.00203	0.0489	CbGeAlD
Duloxetine—NPY1R—liver—sarcoma	0.00192	0.0462	CbGeAlD
Duloxetine—SLC6A3—hematopoietic system—sarcoma	0.00156	0.0375	CbGeAlD
Duloxetine—HTR2A—endothelium—sarcoma	0.00154	0.0371	CbGeAlD
Duloxetine—NPY1R—lymph node—sarcoma	0.00147	0.0354	CbGeAlD
Duloxetine—SLC6A4—hematopoietic system—sarcoma	0.00143	0.0344	CbGeAlD
Duloxetine—CYP1A2—hematopoietic system—sarcoma	0.000967	0.0233	CbGeAlD
Duloxetine—Photosensitivity reaction—Epirubicin—sarcoma	0.000918	0.000958	CcSEcCtD
Duloxetine—Paraesthesia—Etoposide—sarcoma	0.000916	0.000956	CcSEcCtD
Duloxetine—Weight increased—Epirubicin—sarcoma	0.000915	0.000955	CcSEcCtD
Duloxetine—Pancreatitis—Doxorubicin—sarcoma	0.000912	0.000952	CcSEcCtD
Duloxetine—Weight decreased—Epirubicin—sarcoma	0.00091	0.000949	CcSEcCtD
Duloxetine—Hyperglycaemia—Epirubicin—sarcoma	0.000907	0.000946	CcSEcCtD
Duloxetine—Somnolence—Etoposide—sarcoma	0.000907	0.000946	CcSEcCtD
Duloxetine—Hypersensitivity—Mitoxantrone—sarcoma	0.000904	0.000943	CcSEcCtD
Duloxetine—Asthenia—Vincristine—sarcoma	0.000904	0.000943	CcSEcCtD
Duloxetine—Vomiting—Thiotepa—sarcoma	0.000903	0.000942	CcSEcCtD
Duloxetine—Infestation NOS—Epirubicin—sarcoma	0.000897	0.000936	CcSEcCtD
Duloxetine—Infestation—Epirubicin—sarcoma	0.000897	0.000936	CcSEcCtD
Duloxetine—Vomiting—Dactinomycin—sarcoma	0.000896	0.000935	CcSEcCtD
Duloxetine—Rash—Thiotepa—sarcoma	0.000895	0.000934	CcSEcCtD
Duloxetine—Dermatitis—Thiotepa—sarcoma	0.000895	0.000933	CcSEcCtD
Duloxetine—Headache—Thiotepa—sarcoma	0.00089	0.000928	CcSEcCtD
Duloxetine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000889	0.000927	CcSEcCtD
Duloxetine—Rash—Dactinomycin—sarcoma	0.000889	0.000927	CcSEcCtD
Duloxetine—Decreased appetite—Etoposide—sarcoma	0.000887	0.000925	CcSEcCtD
Duloxetine—Renal failure—Epirubicin—sarcoma	0.000881	0.00092	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Etoposide—sarcoma	0.000881	0.000919	CcSEcCtD
Duloxetine—Asthenia—Mitoxantrone—sarcoma	0.00088	0.000918	CcSEcCtD
Duloxetine—Fatigue—Etoposide—sarcoma	0.00088	0.000918	CcSEcCtD
Duloxetine—Jaundice—Epirubicin—sarcoma	0.000874	0.000912	CcSEcCtD
Duloxetine—Stomatitis—Epirubicin—sarcoma	0.000874	0.000912	CcSEcCtD
Duloxetine—Pain—Etoposide—sarcoma	0.000872	0.00091	CcSEcCtD
Duloxetine—Constipation—Etoposide—sarcoma	0.000872	0.00091	CcSEcCtD
Duloxetine—Urinary tract infection—Epirubicin—sarcoma	0.000872	0.000909	CcSEcCtD
Duloxetine—Conjunctivitis—Epirubicin—sarcoma	0.000872	0.000909	CcSEcCtD
Duloxetine—Dysuria—Doxorubicin—sarcoma	0.00087	0.000908	CcSEcCtD
Duloxetine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000865	0.000902	CcSEcCtD
Duloxetine—Diarrhoea—Vincristine—sarcoma	0.000862	0.000899	CcSEcCtD
Duloxetine—Pollakiuria—Doxorubicin—sarcoma	0.00086	0.000897	CcSEcCtD
Duloxetine—SLC6A3—testis—sarcoma	0.000854	0.0206	CbGeAlD
Duloxetine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000849	0.000886	CcSEcCtD
Duloxetine—Hepatobiliary disease—Epirubicin—sarcoma	0.000848	0.000885	CcSEcCtD
Duloxetine—Weight increased—Doxorubicin—sarcoma	0.000847	0.000884	CcSEcCtD
Duloxetine—HTR2A—embryo—sarcoma	0.000847	0.0204	CbGeAlD
Duloxetine—Epistaxis—Epirubicin—sarcoma	0.000846	0.000882	CcSEcCtD
Duloxetine—Nausea—Thiotepa—sarcoma	0.000844	0.00088	CcSEcCtD
Duloxetine—Weight decreased—Doxorubicin—sarcoma	0.000842	0.000878	CcSEcCtD
Duloxetine—Feeling abnormal—Etoposide—sarcoma	0.000841	0.000877	CcSEcCtD
Duloxetine—Hyperglycaemia—Doxorubicin—sarcoma	0.000839	0.000876	CcSEcCtD
Duloxetine—Diarrhoea—Mitoxantrone—sarcoma	0.000839	0.000876	CcSEcCtD
Duloxetine—Nausea—Dactinomycin—sarcoma	0.000837	0.000874	CcSEcCtD
Duloxetine—Gastrointestinal pain—Etoposide—sarcoma	0.000834	0.00087	CcSEcCtD
Duloxetine—Dizziness—Vincristine—sarcoma	0.000833	0.000869	CcSEcCtD
Duloxetine—Infestation NOS—Doxorubicin—sarcoma	0.00083	0.000866	CcSEcCtD
Duloxetine—Infestation—Doxorubicin—sarcoma	0.00083	0.000866	CcSEcCtD
Duloxetine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000823	0.000858	CcSEcCtD
Duloxetine—Renal failure—Doxorubicin—sarcoma	0.000816	0.000851	CcSEcCtD
Duloxetine—Urticaria—Etoposide—sarcoma	0.00081	0.000846	CcSEcCtD
Duloxetine—Haemoglobin—Epirubicin—sarcoma	0.000809	0.000844	CcSEcCtD
Duloxetine—Stomatitis—Doxorubicin—sarcoma	0.000809	0.000844	CcSEcCtD
Duloxetine—Jaundice—Doxorubicin—sarcoma	0.000809	0.000844	CcSEcCtD
Duloxetine—Body temperature increased—Etoposide—sarcoma	0.000806	0.000841	CcSEcCtD
Duloxetine—Abdominal pain—Etoposide—sarcoma	0.000806	0.000841	CcSEcCtD
Duloxetine—Conjunctivitis—Doxorubicin—sarcoma	0.000806	0.000841	CcSEcCtD
Duloxetine—Urinary tract infection—Doxorubicin—sarcoma	0.000806	0.000841	CcSEcCtD
Duloxetine—Hepatitis—Epirubicin—sarcoma	0.000805	0.00084	CcSEcCtD
Duloxetine—Haemorrhage—Epirubicin—sarcoma	0.000805	0.00084	CcSEcCtD
Duloxetine—Hypoaesthesia—Epirubicin—sarcoma	0.000801	0.000836	CcSEcCtD
Duloxetine—Vomiting—Vincristine—sarcoma	0.000801	0.000835	CcSEcCtD
Duloxetine—Pharyngitis—Epirubicin—sarcoma	0.000799	0.000834	CcSEcCtD
Duloxetine—Urinary tract disorder—Epirubicin—sarcoma	0.000795	0.000829	CcSEcCtD
Duloxetine—Rash—Vincristine—sarcoma	0.000794	0.000828	CcSEcCtD
Duloxetine—Dermatitis—Vincristine—sarcoma	0.000793	0.000828	CcSEcCtD
Duloxetine—Oedema peripheral—Epirubicin—sarcoma	0.000793	0.000827	CcSEcCtD
Duloxetine—Connective tissue disorder—Epirubicin—sarcoma	0.000791	0.000825	CcSEcCtD
Duloxetine—Urethral disorder—Epirubicin—sarcoma	0.000789	0.000823	CcSEcCtD
Duloxetine—Headache—Vincristine—sarcoma	0.000789	0.000823	CcSEcCtD
Duloxetine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000785	0.000819	CcSEcCtD
Duloxetine—Epistaxis—Doxorubicin—sarcoma	0.000783	0.000816	CcSEcCtD
Duloxetine—Vomiting—Mitoxantrone—sarcoma	0.00078	0.000814	CcSEcCtD
Duloxetine—Visual impairment—Epirubicin—sarcoma	0.000776	0.000809	CcSEcCtD
Duloxetine—Rash—Mitoxantrone—sarcoma	0.000773	0.000807	CcSEcCtD
Duloxetine—Dermatitis—Mitoxantrone—sarcoma	0.000773	0.000806	CcSEcCtD
Duloxetine—Headache—Mitoxantrone—sarcoma	0.000768	0.000802	CcSEcCtD
Duloxetine—Erythema multiforme—Epirubicin—sarcoma	0.000761	0.000794	CcSEcCtD
Duloxetine—HTR2A—hematopoietic system—sarcoma	0.000756	0.0182	CbGeAlD
Duloxetine—Eye disorder—Epirubicin—sarcoma	0.000752	0.000785	CcSEcCtD
Duloxetine—Hypersensitivity—Etoposide—sarcoma	0.000752	0.000784	CcSEcCtD
Duloxetine—Tinnitus—Epirubicin—sarcoma	0.00075	0.000783	CcSEcCtD
Duloxetine—Haemoglobin—Doxorubicin—sarcoma	0.000749	0.000781	CcSEcCtD
Duloxetine—Nausea—Vincristine—sarcoma	0.000748	0.00078	CcSEcCtD
Duloxetine—Flushing—Epirubicin—sarcoma	0.000747	0.000779	CcSEcCtD
Duloxetine—Cardiac disorder—Epirubicin—sarcoma	0.000747	0.000779	CcSEcCtD
Duloxetine—Haemorrhage—Doxorubicin—sarcoma	0.000745	0.000777	CcSEcCtD
Duloxetine—Hepatitis—Doxorubicin—sarcoma	0.000745	0.000777	CcSEcCtD
Duloxetine—Hypoaesthesia—Doxorubicin—sarcoma	0.000741	0.000773	CcSEcCtD
Duloxetine—Pharyngitis—Doxorubicin—sarcoma	0.000739	0.000771	CcSEcCtD
Duloxetine—Urinary tract disorder—Doxorubicin—sarcoma	0.000736	0.000767	CcSEcCtD
Duloxetine—Oedema peripheral—Doxorubicin—sarcoma	0.000734	0.000765	CcSEcCtD
Duloxetine—Asthenia—Etoposide—sarcoma	0.000732	0.000764	CcSEcCtD
Duloxetine—Connective tissue disorder—Doxorubicin—sarcoma	0.000732	0.000764	CcSEcCtD
Duloxetine—Angiopathy—Epirubicin—sarcoma	0.00073	0.000762	CcSEcCtD
Duloxetine—Urethral disorder—Doxorubicin—sarcoma	0.00073	0.000762	CcSEcCtD
Duloxetine—Nausea—Mitoxantrone—sarcoma	0.000729	0.00076	CcSEcCtD
Duloxetine—HTR2A—connective tissue—sarcoma	0.000728	0.0175	CbGeAlD
Duloxetine—Immune system disorder—Epirubicin—sarcoma	0.000727	0.000759	CcSEcCtD
Duloxetine—Mediastinal disorder—Epirubicin—sarcoma	0.000725	0.000757	CcSEcCtD
Duloxetine—Chills—Epirubicin—sarcoma	0.000722	0.000754	CcSEcCtD
Duloxetine—Pruritus—Etoposide—sarcoma	0.000722	0.000753	CcSEcCtD
Duloxetine—Arrhythmia—Epirubicin—sarcoma	0.000719	0.00075	CcSEcCtD
Duloxetine—Visual impairment—Doxorubicin—sarcoma	0.000718	0.000749	CcSEcCtD
Duloxetine—Alopecia—Epirubicin—sarcoma	0.000711	0.000742	CcSEcCtD
Duloxetine—Mental disorder—Epirubicin—sarcoma	0.000705	0.000736	CcSEcCtD
Duloxetine—Erythema multiforme—Doxorubicin—sarcoma	0.000704	0.000735	CcSEcCtD
Duloxetine—Erythema—Epirubicin—sarcoma	0.000701	0.000731	CcSEcCtD
Duloxetine—Malnutrition—Epirubicin—sarcoma	0.000701	0.000731	CcSEcCtD
Duloxetine—Diarrhoea—Etoposide—sarcoma	0.000698	0.000728	CcSEcCtD
Duloxetine—Eye disorder—Doxorubicin—sarcoma	0.000696	0.000726	CcSEcCtD
Duloxetine—Tinnitus—Doxorubicin—sarcoma	0.000694	0.000725	CcSEcCtD
Duloxetine—Flushing—Doxorubicin—sarcoma	0.000691	0.000721	CcSEcCtD
Duloxetine—Cardiac disorder—Doxorubicin—sarcoma	0.000691	0.000721	CcSEcCtD
Duloxetine—Flatulence—Epirubicin—sarcoma	0.00069	0.00072	CcSEcCtD
Duloxetine—SLC6A2—testis—sarcoma	0.000689	0.0166	CbGeAlD
Duloxetine—CYP2D6—hematopoietic system—sarcoma	0.000689	0.0166	CbGeAlD
Duloxetine—Tension—Epirubicin—sarcoma	0.000688	0.000717	CcSEcCtD
Duloxetine—Dysgeusia—Epirubicin—sarcoma	0.000686	0.000716	CcSEcCtD
Duloxetine—Nervousness—Epirubicin—sarcoma	0.000681	0.00071	CcSEcCtD
Duloxetine—Back pain—Epirubicin—sarcoma	0.000678	0.000707	CcSEcCtD
Duloxetine—Angiopathy—Doxorubicin—sarcoma	0.000676	0.000705	CcSEcCtD
Duloxetine—Dizziness—Etoposide—sarcoma	0.000675	0.000704	CcSEcCtD
Duloxetine—Muscle spasms—Epirubicin—sarcoma	0.000674	0.000703	CcSEcCtD
Duloxetine—Immune system disorder—Doxorubicin—sarcoma	0.000673	0.000702	CcSEcCtD
Duloxetine—Mediastinal disorder—Doxorubicin—sarcoma	0.000671	0.0007	CcSEcCtD
Duloxetine—Chills—Doxorubicin—sarcoma	0.000668	0.000697	CcSEcCtD
Duloxetine—HTR2A—smooth muscle tissue—sarcoma	0.000666	0.016	CbGeAlD
Duloxetine—Arrhythmia—Doxorubicin—sarcoma	0.000665	0.000694	CcSEcCtD
Duloxetine—Vision blurred—Epirubicin—sarcoma	0.00066	0.000689	CcSEcCtD
Duloxetine—Alopecia—Doxorubicin—sarcoma	0.000658	0.000687	CcSEcCtD
Duloxetine—Mental disorder—Doxorubicin—sarcoma	0.000652	0.000681	CcSEcCtD
Duloxetine—Ill-defined disorder—Epirubicin—sarcoma	0.00065	0.000678	CcSEcCtD
Duloxetine—Vomiting—Etoposide—sarcoma	0.000649	0.000677	CcSEcCtD
Duloxetine—Malnutrition—Doxorubicin—sarcoma	0.000648	0.000676	CcSEcCtD
Duloxetine—Erythema—Doxorubicin—sarcoma	0.000648	0.000676	CcSEcCtD
Duloxetine—Anaemia—Epirubicin—sarcoma	0.000648	0.000676	CcSEcCtD
Duloxetine—Agitation—Epirubicin—sarcoma	0.000644	0.000672	CcSEcCtD
Duloxetine—Rash—Etoposide—sarcoma	0.000643	0.000671	CcSEcCtD
Duloxetine—Dermatitis—Etoposide—sarcoma	0.000643	0.000671	CcSEcCtD
Duloxetine—Headache—Etoposide—sarcoma	0.000639	0.000667	CcSEcCtD
Duloxetine—Flatulence—Doxorubicin—sarcoma	0.000639	0.000667	CcSEcCtD
Duloxetine—Tension—Doxorubicin—sarcoma	0.000636	0.000664	CcSEcCtD
Duloxetine—Dysgeusia—Doxorubicin—sarcoma	0.000635	0.000662	CcSEcCtD
Duloxetine—Malaise—Epirubicin—sarcoma	0.000632	0.000659	CcSEcCtD
Duloxetine—Nervousness—Doxorubicin—sarcoma	0.00063	0.000657	CcSEcCtD
Duloxetine—Vertigo—Epirubicin—sarcoma	0.00063	0.000657	CcSEcCtD
Duloxetine—Syncope—Epirubicin—sarcoma	0.000628	0.000656	CcSEcCtD
Duloxetine—Leukopenia—Epirubicin—sarcoma	0.000627	0.000654	CcSEcCtD
Duloxetine—Back pain—Doxorubicin—sarcoma	0.000627	0.000654	CcSEcCtD
Duloxetine—Muscle spasms—Doxorubicin—sarcoma	0.000623	0.00065	CcSEcCtD
Duloxetine—Palpitations—Epirubicin—sarcoma	0.000619	0.000646	CcSEcCtD
Duloxetine—Loss of consciousness—Epirubicin—sarcoma	0.000616	0.000643	CcSEcCtD
Duloxetine—Cough—Epirubicin—sarcoma	0.000611	0.000638	CcSEcCtD
Duloxetine—Vision blurred—Doxorubicin—sarcoma	0.000611	0.000638	CcSEcCtD
Duloxetine—Convulsion—Epirubicin—sarcoma	0.000607	0.000633	CcSEcCtD
Duloxetine—Nausea—Etoposide—sarcoma	0.000606	0.000632	CcSEcCtD
Duloxetine—Hypertension—Epirubicin—sarcoma	0.000605	0.000631	CcSEcCtD
Duloxetine—Ill-defined disorder—Doxorubicin—sarcoma	0.000602	0.000628	CcSEcCtD
Duloxetine—Anaemia—Doxorubicin—sarcoma	0.000599	0.000625	CcSEcCtD
Duloxetine—Arthralgia—Epirubicin—sarcoma	0.000597	0.000622	CcSEcCtD
Duloxetine—Chest pain—Epirubicin—sarcoma	0.000597	0.000622	CcSEcCtD
Duloxetine—Myalgia—Epirubicin—sarcoma	0.000597	0.000622	CcSEcCtD
Duloxetine—Agitation—Doxorubicin—sarcoma	0.000596	0.000622	CcSEcCtD
Duloxetine—Anxiety—Epirubicin—sarcoma	0.000594	0.00062	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000592	0.000618	CcSEcCtD
Duloxetine—Discomfort—Epirubicin—sarcoma	0.000589	0.000615	CcSEcCtD
Duloxetine—Malaise—Doxorubicin—sarcoma	0.000585	0.00061	CcSEcCtD
Duloxetine—Dry mouth—Epirubicin—sarcoma	0.000583	0.000609	CcSEcCtD
Duloxetine—Vertigo—Doxorubicin—sarcoma	0.000582	0.000608	CcSEcCtD
Duloxetine—Syncope—Doxorubicin—sarcoma	0.000581	0.000607	CcSEcCtD
Duloxetine—Leukopenia—Doxorubicin—sarcoma	0.00058	0.000605	CcSEcCtD
Duloxetine—Confusional state—Epirubicin—sarcoma	0.000577	0.000602	CcSEcCtD
Duloxetine—Palpitations—Doxorubicin—sarcoma	0.000573	0.000598	CcSEcCtD
Duloxetine—Anaphylactic shock—Epirubicin—sarcoma	0.000572	0.000597	CcSEcCtD
Duloxetine—Oedema—Epirubicin—sarcoma	0.000572	0.000597	CcSEcCtD
Duloxetine—Loss of consciousness—Doxorubicin—sarcoma	0.00057	0.000595	CcSEcCtD
Duloxetine—Infection—Epirubicin—sarcoma	0.000568	0.000593	CcSEcCtD
Duloxetine—Cough—Doxorubicin—sarcoma	0.000566	0.00059	CcSEcCtD
Duloxetine—Shock—Epirubicin—sarcoma	0.000563	0.000587	CcSEcCtD
Duloxetine—Convulsion—Doxorubicin—sarcoma	0.000562	0.000586	CcSEcCtD
Duloxetine—Nervous system disorder—Epirubicin—sarcoma	0.000561	0.000585	CcSEcCtD
Duloxetine—Thrombocytopenia—Epirubicin—sarcoma	0.00056	0.000584	CcSEcCtD
Duloxetine—Hypertension—Doxorubicin—sarcoma	0.00056	0.000584	CcSEcCtD
Duloxetine—Tachycardia—Epirubicin—sarcoma	0.000558	0.000582	CcSEcCtD
Duloxetine—Skin disorder—Epirubicin—sarcoma	0.000555	0.00058	CcSEcCtD
Duloxetine—Hyperhidrosis—Epirubicin—sarcoma	0.000553	0.000577	CcSEcCtD
Duloxetine—Arthralgia—Doxorubicin—sarcoma	0.000552	0.000576	CcSEcCtD
Duloxetine—Chest pain—Doxorubicin—sarcoma	0.000552	0.000576	CcSEcCtD
Duloxetine—Myalgia—Doxorubicin—sarcoma	0.000552	0.000576	CcSEcCtD
Duloxetine—Anxiety—Doxorubicin—sarcoma	0.00055	0.000574	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000548	0.000572	CcSEcCtD
Duloxetine—Discomfort—Doxorubicin—sarcoma	0.000545	0.000569	CcSEcCtD
Duloxetine—Anorexia—Epirubicin—sarcoma	0.000545	0.000569	CcSEcCtD
Duloxetine—Dry mouth—Doxorubicin—sarcoma	0.00054	0.000563	CcSEcCtD
Duloxetine—Confusional state—Doxorubicin—sarcoma	0.000534	0.000557	CcSEcCtD
Duloxetine—Anaphylactic shock—Doxorubicin—sarcoma	0.000529	0.000552	CcSEcCtD
Duloxetine—Oedema—Doxorubicin—sarcoma	0.000529	0.000552	CcSEcCtD
Duloxetine—Infection—Doxorubicin—sarcoma	0.000526	0.000548	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000521	0.000544	CcSEcCtD
Duloxetine—Shock—Doxorubicin—sarcoma	0.000521	0.000543	CcSEcCtD
Duloxetine—Nervous system disorder—Doxorubicin—sarcoma	0.000519	0.000541	CcSEcCtD
Duloxetine—Thrombocytopenia—Doxorubicin—sarcoma	0.000518	0.000541	CcSEcCtD
Duloxetine—Insomnia—Epirubicin—sarcoma	0.000517	0.00054	CcSEcCtD
Duloxetine—Tachycardia—Doxorubicin—sarcoma	0.000516	0.000539	CcSEcCtD
Duloxetine—Skin disorder—Doxorubicin—sarcoma	0.000514	0.000536	CcSEcCtD
Duloxetine—Paraesthesia—Epirubicin—sarcoma	0.000514	0.000536	CcSEcCtD
Duloxetine—Hyperhidrosis—Doxorubicin—sarcoma	0.000512	0.000534	CcSEcCtD
Duloxetine—Somnolence—Epirubicin—sarcoma	0.000508	0.00053	CcSEcCtD
Duloxetine—Anorexia—Doxorubicin—sarcoma	0.000504	0.000526	CcSEcCtD
Duloxetine—Dyspepsia—Epirubicin—sarcoma	0.000503	0.000525	CcSEcCtD
Duloxetine—CYP1A2—liver—sarcoma	0.000501	0.0121	CbGeAlD
Duloxetine—HTR2A—tendon—sarcoma	0.0005	0.012	CbGeAlD
Duloxetine—SLC6A2—lymph node—sarcoma	0.0005	0.012	CbGeAlD
Duloxetine—Decreased appetite—Epirubicin—sarcoma	0.000497	0.000519	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000494	0.000515	CcSEcCtD
Duloxetine—Fatigue—Epirubicin—sarcoma	0.000493	0.000514	CcSEcCtD
Duloxetine—Pain—Epirubicin—sarcoma	0.000489	0.00051	CcSEcCtD
Duloxetine—Constipation—Epirubicin—sarcoma	0.000489	0.00051	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000482	0.000503	CcSEcCtD
Duloxetine—Insomnia—Doxorubicin—sarcoma	0.000479	0.000499	CcSEcCtD
Duloxetine—Paraesthesia—Doxorubicin—sarcoma	0.000475	0.000496	CcSEcCtD
Duloxetine—Feeling abnormal—Epirubicin—sarcoma	0.000471	0.000492	CcSEcCtD
Duloxetine—Somnolence—Doxorubicin—sarcoma	0.00047	0.000491	CcSEcCtD
Duloxetine—Gastrointestinal pain—Epirubicin—sarcoma	0.000468	0.000488	CcSEcCtD
Duloxetine—Dyspepsia—Doxorubicin—sarcoma	0.000466	0.000486	CcSEcCtD
Duloxetine—Decreased appetite—Doxorubicin—sarcoma	0.00046	0.00048	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000457	0.000477	CcSEcCtD
Duloxetine—Fatigue—Doxorubicin—sarcoma	0.000456	0.000476	CcSEcCtD
Duloxetine—Urticaria—Epirubicin—sarcoma	0.000454	0.000474	CcSEcCtD
Duloxetine—Constipation—Doxorubicin—sarcoma	0.000452	0.000472	CcSEcCtD
Duloxetine—Pain—Doxorubicin—sarcoma	0.000452	0.000472	CcSEcCtD
Duloxetine—Body temperature increased—Epirubicin—sarcoma	0.000452	0.000472	CcSEcCtD
Duloxetine—Abdominal pain—Epirubicin—sarcoma	0.000452	0.000472	CcSEcCtD
Duloxetine—Feeling abnormal—Doxorubicin—sarcoma	0.000436	0.000455	CcSEcCtD
Duloxetine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000433	0.000451	CcSEcCtD
Duloxetine—Hypersensitivity—Epirubicin—sarcoma	0.000421	0.00044	CcSEcCtD
Duloxetine—Urticaria—Doxorubicin—sarcoma	0.00042	0.000439	CcSEcCtD
Duloxetine—Abdominal pain—Doxorubicin—sarcoma	0.000418	0.000436	CcSEcCtD
Duloxetine—Body temperature increased—Doxorubicin—sarcoma	0.000418	0.000436	CcSEcCtD
Duloxetine—HTR2A—testis—sarcoma	0.000414	0.00997	CbGeAlD
Duloxetine—Asthenia—Epirubicin—sarcoma	0.00041	0.000428	CcSEcCtD
Duloxetine—Pruritus—Epirubicin—sarcoma	0.000405	0.000422	CcSEcCtD
Duloxetine—HTR2A—liver—sarcoma	0.000392	0.00943	CbGeAlD
Duloxetine—Diarrhoea—Epirubicin—sarcoma	0.000391	0.000408	CcSEcCtD
Duloxetine—Hypersensitivity—Doxorubicin—sarcoma	0.00039	0.000407	CcSEcCtD
Duloxetine—Asthenia—Doxorubicin—sarcoma	0.00038	0.000396	CcSEcCtD
Duloxetine—Dizziness—Epirubicin—sarcoma	0.000378	0.000395	CcSEcCtD
Duloxetine—CYP2D6—testis—sarcoma	0.000377	0.00909	CbGeAlD
Duloxetine—Pruritus—Doxorubicin—sarcoma	0.000374	0.000391	CcSEcCtD
Duloxetine—Vomiting—Epirubicin—sarcoma	0.000364	0.000379	CcSEcCtD
Duloxetine—Diarrhoea—Doxorubicin—sarcoma	0.000362	0.000378	CcSEcCtD
Duloxetine—Rash—Epirubicin—sarcoma	0.000361	0.000376	CcSEcCtD
Duloxetine—Dermatitis—Epirubicin—sarcoma	0.00036	0.000376	CcSEcCtD
Duloxetine—Headache—Epirubicin—sarcoma	0.000358	0.000374	CcSEcCtD
Duloxetine—CYP2D6—liver—sarcoma	0.000357	0.00859	CbGeAlD
Duloxetine—Dizziness—Doxorubicin—sarcoma	0.00035	0.000365	CcSEcCtD
Duloxetine—Nausea—Epirubicin—sarcoma	0.00034	0.000354	CcSEcCtD
Duloxetine—Vomiting—Doxorubicin—sarcoma	0.000336	0.000351	CcSEcCtD
Duloxetine—Rash—Doxorubicin—sarcoma	0.000334	0.000348	CcSEcCtD
Duloxetine—Dermatitis—Doxorubicin—sarcoma	0.000333	0.000348	CcSEcCtD
Duloxetine—Headache—Doxorubicin—sarcoma	0.000331	0.000346	CcSEcCtD
Duloxetine—Nausea—Doxorubicin—sarcoma	0.000314	0.000328	CcSEcCtD
